Research Article
Synthesis and Biological Evaluation of 4-(3-Hydroxy-benzofuran-2-yl)coumarins
Table 1
Results of antimicrobial activities of the synthesized compounds (2b–k) and (3a–k) MICs (μg/mL).
| Compounds | Gram-positive | Gram-negative | Fungi | Number | R | S. aureus | E. faecalis | S. mutans | E. coli | K. pneumonia | P. aeruginosa | C. albicans | A. fumigatus |
| 2b | 7-CH3 | 0.4 | 50 | 0.2 | 6.25 | 100 | 6.25 | 12.5 | 0.4 | 2c | 6-Cl | 0.4 | 1.6 | 0.2 | 0.2 | 50 | 3.12 | 12.5 | 0.4 | 2d | 6-Br | 0.8 | 25 | 0.4 | 1.6 | 100 | 3.12 | 12.5 | 0.4 | 2e | 6-F | 0.4 | 3.12 | 0.2 | 1.6 | 100 | 6.25 | >100 | 0.8 | 2f | 5,6-benzo | 0.4 | 50 | 0.2 | 6.25 | 100 | 6.25 | 12.5 | 0.4 | 2g | 6,8-dimethyl | 1.6 | 0.8 | 0.8 | 3.12 | 100 | 50 | 100 | 1.6 | 2h | 6-isopropyl | 0.8 | 6.25 | 0.4 | 0.4 | 100 | 25 | 12.5 | 0.4 | 2i | 6-tert-butyl | 0.8 | 6.25 | 0.8 | 0.2 | 100 | 25 | 12.5 | 0.2 | 2j | 6-benzyl | 0.8 | 12.5 | 0.4 | 1.6 | 100 | 6.25 | 100 | 0.8 | 2k | 6-OMe | 0.8 | 3.12 | 0.8 | 3.12 | 100 | 100 | 100 | 0.8 | 3a | 6-CH3 | 0.2 | 0.2 | 0.2 | 50 | 100 | 50 | 12.5 | — | 3b | 7-CH3 | 0.2 | 0.2 | 0.2 | 100 | 50 | >100 | 0.2 | — | 3c | 6-Cl | 0.2 | 0.4 | 0.2 | 100 | 100 | 25 | 3.12 | — | 3d | 6-Br | — | — | — | — | — | — | — | — | 3e | 6-F | 0.2 | 0.4 | 0.4 | 100 | 100 | >100 | 0.2 | — | 3f | 5,6-benzo | 0.2 | 0.4 | 3.12 | 50 | 100 | 0.2 | 0.2 | — | 3g | 6,8-dimethyl | 0.2 | 0.4 | 0.2 | 100 | 100 | 50 | 0.2 | — | 3h | 6-isopropyl | 0.2 | 0.4 | 0.2 | 50 | 100 | 3.12 | 0.2 | — | 3i | 6-tert-butyl | 0.2 | 0.8 | 0.2 | 50 | >100 | 6.25 | 0.2 | — | 3j | 6-benzyl | 0.2 | 0.8 | 0.2 | 100 | 100 | 50 | 0.2 | — | 3k | 6-OMe | 0.2 | 0.4 | 3.12 | 50 | 100 | 6.25 | 0.2 | — | Ciprofloxacin | 2 | 2 | 2 | 1 | 1 | 4 | — | — | Fluconazole | — | — | — | — | — | — | 16 | 8 |
|
|